STEMI patients with diabetes show higher mortality following PCI

09/23/2013 | Healio

Diabetes patients who underwent percutaneous coronary intervention for STEMI had nearly four times the mortality rate of those without diabetes, according to results from the INFUSE-AMI trial. Researchers also found those with diabetes had more extensive left anterior descending artery disease and a higher 30-day revascularization rate compared with the nondiabetes cohort. The findings appear in the journal Catheterization and Cardiovascular Interventions.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA